1-3 of 3
Saman Khalid Hashmi
Close
Save search
Sort by
Journal Articles

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies

Free
Raoul Tibes, MD PhD, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Jeanne Palmer, MD, James L. Slack, MD, Emily Ann Knight, NP, Saman Khalid Hashmi, MD, James M. Bogenberger, PhD, Darci Zblewski, CNP, William J. Hogan, MBBCh, Mark R. Litzow, MD, Ruben A Mesa, MD, James M. Foran, MD, Lisa Sproat, MD MSW, Aref Al-Kali, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2629.
https://doi.org/10.1182/blood.V130.Suppl_1.2629.2629
Published: 2017
Journal Articles

The Unfolded Protein Response As a Predictor of Chemosensitivity in Pediatric Acute Myeloid Leukemia

Free
Saman Khalid Hashmi, MD, Mia Hofstad, Nenggang Zhang, PhD, Gaye Jenkins, BS, Terzah M. Horton, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5106.
https://doi.org/10.1182/blood.V130.Suppl_1.5106.5106
Published: 2017
Journal Articles

Aberrant Precursor B Lymphoid Blast Population in a Patient with Juvenile Myelomonocytic Leukemia

Free
Saman Khalid Hashmi, MD, Jyotinder Nain Punia, MD, Amos S. Gaikwad, PhD, Kevin E. Fisher, MD PhD, Angshumoy Roy, MD PhD, Dolores H. Lopez-Terrada, MD PhD, Pulivarthi Rao, PhD, Jo Ringrose, CG(ASCP), Andrea N. Marcogliese, MD, Rachel E Rau, MD
Journal: Blood
Blood (2016) 128 (22): 5557.
https://doi.org/10.1182/blood.V128.22.5557.5557
Published: 2016